Ultragenyx Pharmaceutical
Jeffrey Katsch, CPA, currently serves as Senior Manager of SEC Reporting at Ultragenyx Pharmaceutical Inc. since June 2021, previously holding the position of SEC Reporting Manager. Prior experience includes a tenure at BPM LLP from November 2015 to June 2021, where roles ranged from Assurance Manager to Assurance Associate, focusing on audits, compliance, and financial reporting for public and private entities, particularly in the technology sector. Educational accomplishments include a Bachelor of Science in Finance from San Francisco State University along with study abroad programs at Nanjing University and National Taiwan University. Early work experience involved customer service as a server at Cafe Citti and accounting support at Guangzhou Weimei Investment Ltd.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.